Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1990 of 5804
-
Smarter spinal stimulator aims to ease chronic pain without the jolt
Symptom relief CompletedThe purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.
Phase: NA • Sponsor: MedtronicNeuro • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can free produce help kids with diabetes? new study tests vouchers
Disease control Recruiting nowRady Children's Hospital San Diego (RCHSD), UCSD Division of Child and Community Health and the Center for Community Health, and Northgate Gonzalez (NG) Markets will collaborate to create a Produce Prescription Program (Fruit and Vegetable Prescription Program) to be implemented …
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Smarter brain stimulator could save battery life in Parkinson's patients
Symptom relief CompletedThe purpose of the study is to evaluate the efficacy of aDBS (preferred mode, single or dual threshold) vs standard continuous DBS (cDBS) in decreasing Total Electrical Energy Delivered (TEED). Prospective randomized, single-blind, crossover, multicenter study of aDBS in subjects…
Phase: NA • Sponsor: MedtronicNeuro • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
3D-Printed skull implants: a safer way to fix head defects?
Disease control OngoingThis study is a non-randomised and single center study with patients needing an artificial skull bone eg cranioplasty. 40 patients will be implanted with in house manufactured polyether ether ketone (PEEK) implants using a fused filament fabrication 3D printer. The primary aim is…
Phase: NA • Sponsor: Skane University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Simple stretch may speed diaphragm recovery after heart surgery
Disease control CompletedPostoperative respiratory complications are common complications of patients after cardiac surgery and increase morbidity and mortality and hospital length of stay. Diaphragmatic dysfunction accounts for between 2 and 15% of these complications. Diaphragmatic paresis is one of th…
Phase: NA • Sponsor: CMC Ambroise Paré • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Zapping nerves to tame a fluttering heart: new hope for AFib?
Disease control CompletedThe purpose of this study is to examine if sending mild electrical signals just under your skin will improve atrial fibrillation symptoms by controlling your heart rate.
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Single-Lead ICD that spots hidden heart rhythm problems
Disease control CompletedTo demonstrate the value and benefits of BIOTRONIK's exclusive DX technology in assessing the incidence of supraventricular arrhythmias, mainly atrial fibrillation (AF), in patients with an indication for single chamber ICDs. Effects of the DX technology on related events, such …
Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Major study aims to uncover why diabetic foot ulcers lead to early death
Knowledge-focused Recruiting nowThe worse prognosis observed in patients with Diabetic Foot Ulcer (DFU) has not been fully understood. Poor prognosis may be related to other conditions (inflammation, infectious disease, cancers) further to cardiovascular disease. The aim of the study is to conduct the first pr…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Mayo clinic launches quest for custom drugs for rare genetic diseases
Knowledge-focused ENROLLING_BY_INVITATIONThe purpose of this research study is to identify individuals that have a rare genetic disease without an adequate therapeutic strategy that might be treatable with drug developed to target the disease-causing genetic alteration.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Immune cell shifts after colorectal surgery may predict who stays Cancer-Free
Knowledge-focused Recruiting nowThis is a multi-center, prospective, non-interventional real-world study. In a real-world environment, in line with the current status of the domestic diagnosis and treatment process, and on the premise of not increasing the burden of patients and medical resources, we explore th…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Personalized prediabetes treatment: genetics may predict who benefits from ozempic
Knowledge-focused Recruiting nowThis project uses both transcriptomic- and genomic-level data to identify mechanisms of individual responses to glucagon-like peptide-1 (GLP-1) in Mexican-Americans with prediabetes. The GLP-1 hormone is essential for glucose reduction, weight loss, cardiovascular risk reduction,…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could a chair cure your bladder troubles?
Symptom relief Recruiting nowThe purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of …
Phase: NA • Sponsor: Corewell Health East • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Nasal spray could be new weapon against COVID-19
Prevention TerminatedA multicenter, randomized, double-blinded, placebo-controlled, phase 3 clinical efficacy study evaluating nitric oxide nasal spray (NONS) as prevention for treatment of individuals at risk of exposure to COVID-19 infection.
Phase: PHASE3 • Sponsor: Sanotize Research and Development corp. • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Kidney transplant drug switch under study
Disease control OngoingThe purpose of this study is to evaluate the efficacy and Safety after conversion to RaparoBell® or Myrept® in patients who in renal transplant patients undergoing maintenance therapy with Mycophenolic acid.
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
800-Patient study aims to tailor sarcoma treatment
Knowledge-focused Recruiting nowThis is a cohort study aimed at developing a stratified medicine approach for personalised neoadjuvant chemotherapy (NCT) in high-risk soft tissue sarcoma (STS) patients with dedifferentiated liposarcoma (DDLPS), leiomyosarcoma (LMS), synovial sarcoma (SS), vascular sarcomas, mal…
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Spine surgery showdown: new titanium cage may fuse bones faster
Disease control OngoingThe purpose of this randomized controlled trial is to assess and compare radiographic and clinical outcomes in patients who are to undergo combined interbody/posterolateral lumbar fusion procedures, supplemented with pedicle screw instrumentation, using one of the following inter…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Chocolate compound tested to boost walking in older adults with leg artery disease
Symptom relief Recruiting nowAmong people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less decline in six-minute walk distance at six-month follow-up, compared to those r…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Booster battle: which COVID-19 vaccine boosts immunity best?
⭐️ VACCINE ⭐️ CompletedRandomized comparison of 3rd dose with inactivated vaccine (CoronaVac) or mRNA vaccine (Comirnaty) in adults who previously received two doses of CoronaVac (Sinovac) or two doses of BNT162b2 (Comirnaty, BioNTech/Fosun Pharma) at least 6 months earlier.
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
New MS drug shows promise for asian patients in safety trial
Disease control CompletedThe primary objectives of this study are to determine the safety and tolerability of DRF administered for up to 24 weeks in adult East Asian participants with RMS (Part 1) and to determine the safety and tolerability of DRF administered for up to 48 weeks in adult East Asian part…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can personalized coaching help hispanic kids stay healthy? new trial aims to find out
Prevention OngoingOne-size-fits-all approaches have failed to demonstrate sustained effects on childhood obesity, especially among low-income minority families, who experience constantly changing barriers to engaging in health behavior. Addressing obesity in these populations requires intervening …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC